Saving the brain from catheter ablation of atrial fibrillation: the role of pre- and peri-procedural anticoagulation

Jared T Bunch
Scott C Woller
Abstract

Atrial fibrillation (AF) ablation is an established therapy for symptomatic AF. As a non-pharmacological therapy for AF that in ∼60–70% of patients provides a durable reduction in AF recurrence risk, there exists hope that AF-related co-morbidities may be reduced. Large observational trials have shown that AF ablation is associated with lower rates of stroke, dementia, heart failure, and mortality.1,2

Read More

Citation
Eur Heart J. 31 January, 2019. Epub ahead of print.